YOU ARE HERE: LAT HomeCollectionsJeremy Rifkin

Jeremy Rifkin

January 12, 1993 | From a Times Staff Writer
Shares of agricultural biotechnology pioneer Calgene took a drubbing on the stock market Monday in response to reports that Campbell Soup, one of Calgene's primary supporters in the development of its genetically engineered tomato, was backing away from its commitment. Calgene characterized as "inaccurate and misleading" a report from the activist group Pure Food Campaign that Campbell Soup was withdrawing its support--a potential blow to both Calgene and the fledgling ag-biotech industry.
August 24, 1989 | From Staff and Wire Reports
A biotechnology critic on Wednesday announced that five large supermarket chains have said they will not sell milk from cows treated with a genetically engineered growth hormone. But two of the chains, Vons and Safeway, say their position on the experimental bovine growth hormone, or BGH, is nothing new. "It's not really an issue for us," said Vickie Sanders, spokeswoman for the El Monte-based Vons chain. "We buy milk from one source and the source doesn't use it."
April 25, 2014 | By Alexandra Le Tellier
Lyft, the ride-sharing service known for the pink furry mustache on its drivers' cars, is growing. The company expanded into 24 mid-size cities across the country Thursday. It's great news for the sharing economy. But should we really be celebrating a system that is, in effect, a Band-Aid solution for unemployment and those people struggling financially in post-recession America? I'm not necessarily opposed to the sharing economy, though I did have a frightening Uber experience with a speeding, texting driver, and personally I'd rather stay in a hotel over an Airbnb home rental, which kind of creeps me out. As Jeremy Rifkin recently wrote in our Op-Ed pages , it's a “winning economic model” that “will change the course of economic history.” Using Airbnb as an example, Rifkin attributed the success of sharing services to “near zero marginal cost,” a new phenomenon he says that allows companies to expand without much of a financial investment.
April 8, 1992 | PETER H. KING
So maybe I didn't read much Tolstoy in college. Maybe I went untutored in the fine points of Descartes and other philosophers. At least my academic career here at Cal Poly was not a complete waste. At least I got to stick my arm inside the stomach of a cow. The animal in question was what is called a fistulated cow. It sported a tidy, and painless, porthole in one side. We searchers of higher knowledge were instructed by our animal science professor to snap on plastic gloves and stand in line.
January 31, 1989 | MARLENE CIMONS, Times Staff Writer
A federal scientific advisory panel, which earlier this month approved the first experiments involving the transfer of genetically altered cells into humans, Monday rejected a proposal to establish an outside review committee to consider the social and ethical implications of such research.
December 12, 2004 | Anthony Pagden, Anthony Pagden is professor of history and political science at UCLA and the author of many books, including "Peoples and Empires" and "European Encounters With the New World."
On Oct. 29, the leaders of the European Union's 25 member countries gathered to sign their first constitution. It still must be ratified by each nation's government, but the signing was, nevertheless, a highly significant moment. The people of Europe are now more united than at any time since Rome's golden age in the 2nd century.
September 1, 2003 | Jeremy Rifkin
Though much of big science has centered on breakthroughs in biotechnology, nanotechnology and more esoteric questions like the age of our universe, a quieter story has been unfolding behind the scenes in laboratories around the world -- one whose effect on human perception and our understanding of life is likely to be profound. What these researchers are finding is that many of our fellow creatures are more like us than we had ever imagined.
Los Angeles Times Articles